• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病和弥漫性路易体病中的糖氧化和氧化应激

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

作者信息

Castellani R, Smith M A, Richey P L, Perry G

机构信息

Department of Pathology (Neuropathology), University of Maryland, Baltimore 21201-1595, USA.

出版信息

Brain Res. 1996 Oct 21;737(1-2):195-200. doi: 10.1016/0006-8993(96)00729-9.

DOI:10.1016/0006-8993(96)00729-9
PMID:8930366
Abstract

Oxidative stress is well accepted as an important pathogenic factor in Parkinson disease, based largely on indirect evidence. Recently, we have developed antibodies that recognize specific advanced glycation end-products (anti-pentosidine and anti-pyrraline), protein modifications that are potentiated by oxidative stress in a process termed glycoxidation. We applied these antibodies immunocytochemically to affected regions in Parkinson disease and diffuse Lewy body disease brains. Additionally, we used antibodies to heme oxygenase-1, a putative marker of oxidative stress response. Immunoreactivity to pentosidine, pyrraline, and heme oxygenase-1 was seen in the substantia nigra of Parkinson disease and the neocortex of diffuse Lewy body disease. Heme oxygenase-1 was further demonstrated by immunoelectron microscopy in intimate association with filaments of cortical Lewy bodies. Immunolocalization of advanced glycation end-products and a marker of oxidative stress response induction provides evidence that glycoxidation and oxidative stress may be an important pathogenic factor in diseases characterized by Lewy body formation, and furthers the evidence that cytoskeletal proteins and their inclusions are susceptible to oxidative stress.

摘要

氧化应激作为帕金森病的一个重要致病因素已被广泛接受,这主要基于间接证据。最近,我们研发出了能够识别特定晚期糖基化终产物的抗体(抗戊糖苷和抗吡咯赖氨酸),这些蛋白质修饰在一个被称为糖氧化的过程中会因氧化应激而增强。我们将这些抗体用于帕金森病和弥漫性路易体病大脑中受影响区域的免疫细胞化学检测。此外,我们还使用了针对血红素加氧酶-1的抗体,它被认为是氧化应激反应的一个标志物。在帕金森病的黑质和弥漫性路易体病的新皮质中观察到了对戊糖苷、吡咯赖氨酸和血红素加氧酶-1的免疫反应性。通过免疫电子显微镜进一步证实,血红素加氧酶-1与皮质路易体的细丝紧密相关。晚期糖基化终产物的免疫定位以及氧化应激反应诱导标志物的检测提供了证据,表明糖氧化和氧化应激可能是路易体形成相关疾病的一个重要致病因素,进一步证明细胞骨架蛋白及其包涵体易受氧化应激影响。

相似文献

1
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.帕金森病和弥漫性路易体病中的糖氧化和氧化应激
Brain Res. 1996 Oct 21;737(1-2):195-200. doi: 10.1016/0006-8993(96)00729-9.
2
Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.亚历山大病患者中罗森塔尔纤维的晚期糖基化修饰
Neurosci Lett. 1997 Aug 8;231(2):79-82. doi: 10.1016/s0304-3940(97)00521-1.
3
Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.食品和化学模型中戊糖素和派拉林的综述:形成、潜在风险和测定。
J Sci Food Agric. 2018 Jul;98(9):3225-3233. doi: 10.1002/jsfa.8853. Epub 2018 Feb 22.
4
Evidence of oxidative stress in the neocortex in incidental Lewy body disease.散发性路易体病新皮质中氧化应激的证据。
J Neuropathol Exp Neurol. 2005 Sep;64(9):816-30. doi: 10.1097/01.jnen.0000179050.54522.5a.
5
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.羟基壬烯醛加合物表明脂质过氧化在人类新皮质和脑干路易小体中发挥作用。
Neurosci Lett. 2002 Feb 8;319(1):25-8. doi: 10.1016/s0304-3940(01)02514-9.
6
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.人阴茎中的晚期糖基化终末产物:糖尿病组织中的升高、沉积部位以及通过诱导型一氧化氮合酶或内皮型一氧化氮合酶可能产生的影响。
Urology. 1997 Dec;50(6):1016-26. doi: 10.1016/S0090-4295(97)00512-8.
7
High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress.特应性皮炎急性加重期儿童尿中高水平的戊糖苷(一种晚期糖基化终产物):与氧化应激的关系
Metabolism. 2003 Dec;52(12):1601-5. doi: 10.1016/s0026-0495(03)00310-x.
8
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.糖尿病性肾小球病变中糖氧化产物与脂质过氧化产物的免疫组织化学共定位。对糖尿病肾病发病机制中糖氧化应激的意义。
J Clin Invest. 1997 Dec 15;100(12):2995-3004. doi: 10.1172/JCI119853.
9
Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.特发性帕金森病中神经血红素加氧酶-1的表达
Exp Neurol. 1998 Mar;150(1):60-8. doi: 10.1006/exnr.1997.6752.
10
Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes.1型糖尿病年轻患者中晚期糖基化终末产物的形成与氧化应激
Pediatr Res. 2003 Sep;54(3):419-24. doi: 10.1203/01.PDR.0000076662.72100.74. Epub 2003 May 21.

引用本文的文献

1
Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies.靶向赖氨酸的淀粉样蛋白聚集抑制剂:对神经退行性蛋白质病的前景
JACS Au. 2025 Aug 11;5(8):3680-3700. doi: 10.1021/jacsau.5c00269. eCollection 2025 Aug 25.
2
Glycation of Proteins and Its End Products: From Initiation to Natural Product-Based Therapeutic Preventions.蛋白质糖基化及其终产物:从起始到基于天然产物的治疗性预防
ACS Pharmacol Transl Sci. 2025 Feb 25;8(3):636-653. doi: 10.1021/acsptsci.4c00684. eCollection 2025 Mar 14.
3
Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases.
蛋白质聚集和神经退行性疾病中的非酶促翻译后蛋白质修饰
RSC Chem Biol. 2024 Dec 19;6(2):129-149. doi: 10.1039/d4cb00221k. eCollection 2025 Feb 5.
4
Advanced Glycation End Products in Neurodegenerative Diseases.神经退行性疾病中的晚期糖基化终末产物
J Mol Neurosci. 2024 Dec 10;74(4):114. doi: 10.1007/s12031-024-02297-1.
5
Dysregulation of a Heme Oxygenase-Synuclein Axis in Parkinson Disease.帕金森病中血红素加氧酶-突触核蛋白轴的失调
NeuroSci. 2022 May 20;3(2):284-299. doi: 10.3390/neurosci3020020. eCollection 2022 Jun.
6
Posttranslational Modifications of -Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.- 突触核蛋白的翻译后修饰、它们的治疗潜力,以及在健康和神经退行性疾病中的相互作用。
Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111.
7
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms.糖尿病与帕金森病:共同分子机制的认识。
J Parkinsons Dis. 2024;14(5):917-924. doi: 10.3233/JPD-230104.
8
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
9
Advanced glycation end products consumption and the decline of functional capacity in patients with Parkinson's disease: Cross-sectional study.晚期糖基化终产物的摄入与帕金森病患者功能能力下降的关系:横断面研究。
Clinics (Sao Paulo). 2024 Jan 30;79:100320. doi: 10.1016/j.clinsp.2023.100320. eCollection 2024.
10
Behavioral and histological assessment of a novel treatment of neuroHIV in humanized mice.人源化小鼠中新型神经艾滋病治疗方法的行为学和组织学评估
Res Sq. 2023 Dec 13:rs.3.rs-3678629. doi: 10.21203/rs.3.rs-3678629/v1.